HighVista Biotechnology Opportunities Fund LP — Form D/A

HighVista Biotechnology Opportunities Fund LP of BOSTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2025-07-11. $434.9M was reported sold. Industry: Pooled Investment Fund.

Offering

Filed: 2025-07-11
Form: D/A
Accession: 0001816829-25-000002
Industry: Pooled Investment Fund
Exemptions: 06b, 3C, 3C.7
Amount sold: $434.9M
Minimum investment: $500K
Investors: 50
Date of first sale: 2020-07-01
Security types: fund interests
SEC file number: 021-371199

Issuer

Name: HighVista Biotechnology Opportunities Fund LP
CIK: 0001816829
Entity type: Limited Partnership
Jurisdiction: DELAWARE
Incorporated: 2020
Address: C/O HIGHVISTA STRATEGIES LLC 200 CLARENDON STREET, 50TH FLOOR, BOSTON, MA, 02116
Phone: (617) 406-6500

Officers, directors & promoters (2)

Name	Role	Location
N/A HighVista GP VII Limited Partnership	Executive Officer	Boston, MA
n/a HighVista Strategies LLC	Executive Officer	Boston, MA

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2026-07-06	D/A	—	$453.2M
2024-07-12	D/A	—	$396.5M
2023-07-13	D/A	—	$377.3M
2022-07-15	D/A	—	$358.4M
2021-07-15	D/A	—	$200.6M
2021-04-12	D/A	—	$200.6M
2021-01-14	D/A	—	$192.4M
2020-07-16	D	—	$147.5M

More